نتائج البحث - Tadashi Matsushita

تنقيح النتائج
  1. 1
    Identification of Amino Acid Residues Essential for von Willebrand Factor Binding to Platelet Glycoprotein Ib.

    Identification of Amino Acid Residues Essential for von Willebrand Factor Binding to Platelet Glycoprotein Ib. حسب Tadashi Matsushita, J. Evan Sadler

    منشور في 1995
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor

    Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor حسب Jeroen Eikenboom, Tadashi Matsushita, PH Reitsma, EA Tuley, Giancarlo Castaman, E Briët, J. Evan Sadler

    منشور في 1996
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa

    Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa حسب Steven R. Lentz, S. Ehrenforth, Faraizah Abdul Karim, Tadashi Matsushita, Karin Weldingh, Jerzy Windyga, Johnny Mahlangu

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Immunofluorescence Analysis of Neutrophil Nonmuscle Myosin Heavy Chain-A in MYH9 Disorders: Association of Subcellular Localization with MYH9 Mutations

    Immunofluorescence Analysis of Neutrophil Nonmuscle Myosin Heavy Chain-A in MYH9 Disorders: Association of Subcellular Localization with MYH9 Mutations حسب Shinji Kunishima, Tadashi Matsushita, Tetsuhito Kojima, Masahiro Sako, Fumihiro Kimura, Eun‐Kyeong Jo, Chikako Inoue, Tadashi Kamiya, Hidehiko Saito

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A

    Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A حسب Midori Shima, Hideji Hanabusa, Masashi Taki, Tadashi Matsushita, Tetsuji Sato, Katsuyuki Fukutake, Naoki Fukazawa, Koichiro Yoneyama, Hiroki Yoshida, Keiji Nogami

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors

    Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors حسب Midori Shima, Hideji Hanabusa, Masashi Taki, Tadashi Matsushita, Tetsuji Sato, Katsuyuki Fukutake, Ryu Kasai, Koichiro Yoneyama, Hiroki Yoshida, Keiji Nogami

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Structural and functional insights into S-thiolation of human serum albumins

    Structural and functional insights into S-thiolation of human serum albumins حسب Fumie Nakashima, Takahiro Shibata, Kohei Kamiya, Jun Yoshitake, Ryosuke Kikuchi, Tadashi Matsushita, Isao Ishii, Juan Antonio Giménez‐Bastida, Claus Schneider, Kôji Uchida

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Stress Augments Insulin Resistance and Prothrombotic State

    Stress Augments Insulin Resistance and Prothrombotic State حسب Yasuhiro Uchida, Kyosuke Takeshita, Koji Yamamoto, Ryosuke Kikuchi, Takayuki Nakayama, Mieko Nomura, Xian Wu Cheng, Kensuke Egashira, Tadashi Matsushita, Hideo Nakamura, Toyoaki Murohara

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Complete antithrombin deficiency in mice results in embryonic lethality

    Complete antithrombin deficiency in mice results in embryonic lethality حسب Kazuhiro Ishiguro, Tetsuhito Kojima, Kenji Kadomatsu, Yukiko Nakayama, Akira Takagi, Misao Suzuki, Naoki Takeda, Masafumi Ito, Koji Yamamoto, Tadashi Matsushita, Kazuo Kusugami, Takashi Muramatsu, Hidehiko Saito

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Syndecan-4 Deficiency Leads to High Mortality of Lipopolysaccharide-injected Mice

    Syndecan-4 Deficiency Leads to High Mortality of Lipopolysaccharide-injected Mice حسب Kazuhiro Ishiguro, Kenji Kadomatsu, Tetsuhito Kojima, Hisako Muramatsu, Mitsunori Iwase, Yasunobu Yoshikai, Masamitsu Yanada, Koji Yamamoto, Tadashi Matsushita, Masahiko Nishimura, Kazuo Kusugami, Hidehiko Saito, Takashi Muramatsu

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis

    Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis حسب Bethany Samuelson Bannow, Michael Recht, Claude Négrier, Cédric Hermans, Erik Berntorp, Hermann Eichler, Maria Elisa Mancuso, Robert Klamroth, Jamie O’Hara, Elena Santagostino, Tadashi Matsushita, Craig M. Kessler

    منشور في 2019
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

    Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial حسب Peter W. Collins, Guy Young, Karin Knobe, Faraizah Abdul Karim, Pantep Angchaisuksiri, Claus Banner, Türkiz Gursel, Johnny Mahlangu, Tadashi Matsushita, Eveline P. Mauser‐Bunschoten, Johannes Oldenburg, Christopher Walsh, Claude Négrier

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Thrombosis from a Prothrombin Mutation Conveying Antithrombin Resistance

    Thrombosis from a Prothrombin Mutation Conveying Antithrombin Resistance حسب Yuhri Miyawaki, Atsuo Suzuki, Junko Fujita, Asuka Maki, Eriko Okuyama, Moe Murata, Akira Takagi, Takashi Murate, Shinji Kunishima, Michio Sakai, Kohji Okamoto, Tadashi Matsushita, Tomoki Naoe, Hidehiko Saito, Tetsuhito Kojima

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice

    Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice حسب Maimaiti Yisireyili, Motoharu Hayashi, Hongxian Wu, Yasuhiro Uchida, Koji Yamamoto, Ryosuke Kikuchi, Mohammad Shoaib Hamrah, Takayuki Nakayama, Xian Wu Cheng, Tadashi Matsushita, Shigeo Nakamura, Toshimitsu Niwa, Toyoaki Murohara, Kyosuke Takeshita

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results

    Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results حسب Amy D. Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Pratima Chowdary, Hermann Eichler, Víctor Jiménez‐Yuste, Kaan Kavaklı, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P. Wheeler, Guy Young, Silva Zupančić‐Šalek, Johannes Oldenburg

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors

    Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors حسب Amy D. Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Hermann Eichler, Víctor Jiménez‐Yuste, Kaan Kavaklı, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P. Wheeler, Guy Young, Silva Zupančić‐Šalek, Johannes Oldenburg, Pratima Chowdary

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Identification of six novel MYH9 mutations and genotype–phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions

    Identification of six novel MYH9 mutations and genotype–phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions حسب Shinji Kunishima, Tadashi Matsushita, Toshiya Kojima, N Amemiya, Y. M. Choi, Naoki Hosaka, M. Inoue, Jung Yh, S Mamiya, Kiyoshi Matsumoto, Yuji Miyajima, Guolong Zhang, Changgeng Ruan, Kazuto Saito, K S Song, H.-J. Yoon, T. Kamiya, Hajime Saito

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    International consensus recommendations on the management of people with haemophilia B

    International consensus recommendations on the management of people with haemophilia B حسب Daniel P. Hart, Davide Matino, Jan Astermark, Gerard Dolan, Roseline d’Oiron, Cédric Hermans, Víctor Jiménez‐Yuste, Adriana Linares, Tadashi Matsushita, Simon McRae, Margareth C. Ozelo, Sean Platton, Darrel W. Stafford, Robert F. Sidonio, Andreas Tiede

    منشور في 2022
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease

    An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease حسب Ryosuke Kikuchi, Kazuto Nakamura, Susan MacLauchlan, Doan Thi-Minh Ngo, Ippei Shimizu, José J. Fuster, Yasufumi Katanasaka, Sumiko Yoshida, Yan Qiu, Terry P. Yamaguchi, Tadashi Matsushita, Toyoaki Murohara, Noyan Gokce, David O. Bates, Naomi M. Hamburg, Kenneth Walsh

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study

    Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extensio... حسب John Pasi, Kathelijn Fischer, Margaret V. Ragni, Roshni Kulkarni, Margareth C. Ozelo, Johnny Mahlangu, Amy D. Shapiro, Stephanie P’ng, Hérvè Chambost, Beatrice Nolan, Carolyn M. Bennett, Tadashi Matsushita, Bent Winding, Joachim Fruebis, Huixing Yuan, Dan Rudin, Johannes Oldenburg

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: